NCT04284293View on ClinicalTrials.gov

CNS10-NPC for the Treatment of RP

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Retinitis Pigmentosa
Interventions
BIOLOGICAL

CNS10-NPC implantation

All patients will receive a single, unilateral, subretinal injection of CNS10-NPC

Trial Locations (1)

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

All Listed Sponsors
collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

Cedars-Sinai Medical Center

OTHER